Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001327111-26-000002

President and CEO sold 7,455 shares at $23.39 ($174,372)

From the SEC's structured data for this filing

Trades in this filing

Seely Lynn · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-11 Sale : show line 1 in the form −7,455 $23.39 $174,372 74,266 D
Open-market sales · 7,455 sh · avg $23.39 · $174,372
Loading xslF345X05/form4-02132026_010246.xml…